Introduction
============

During adulthood, the cognitive performance and immunity system begins to decline concurrently prior to the third decade of life suggesting that the mechanisms underlying these processes are inter-related ([@B75]). There is comparable evidence indicating that increases in the level of peripheral markers of inflammation are associated with age-related declines in the health of the brain ([@B34]). Such evidence is parallel to longstanding findings from neurocognitive studies in populations of older adults living in a community, that indicate in a consistent manner an association between higher inflammatory levels and lower cognitive levels and a higher risk of cognitive impairment over time ([@B39]).

The systemic inflammation related to aging involves multiple organs and represents a common mechanism leading to multiple chronic diseases such as dementia, diabetes, atherosclerosis, and arthritis, which has a negative impact on the health span of the elderly ([@B57]; [@B34]; [@B40]). These findings supported the 'inflammaging theory' that hypothesizes a global reduction in the capacity to cope with a variety of stressors and purposes a concomitant progressive cytokines dysregulation as the major characteristics of the aging process ([@B35]).

The modification of the Hypothalamus Pituitary Adrenal (HPA) axis activity represents another hallmark of the aging phenotype ([@B30]). Several findings suggest that a higher basal endogenous cortisol (C) concentration, a downstream effect of the increase in basal tonus of the HPA axis activation, is age-related ([@B23]; [@B38]). The enhanced HPA axis activity could be explained by a decrease of the hippocampal inhibitory function that leads to an increase of the release of C ([@B22]). Consistently, the aging related higher plasma levels of C have predicted a smaller hippocampal volume, faster hippocampal atrophy ([@B55]; [@B66]), that are associated to memory decline, and to general poor cognitive performance ([@B56]; [@B51]; [@B91]; [@B37]; [@B94]).

The aging systemic higher exposure to C could be associated with the accelerated features of low-grade inflammation that characterizes older adults. The HPA axis activity exerts a pivotal role for the homeostasis of the immune system. The circulating level of C and those of several cytokines have been concurrently associated with a decreased hippocampal volume and cognitive impairment ([@B4]; [@B86]; [@B62]; [@B16]; [@B48]). The Glucocorticoids (GCs) and pro-inflammatory cytokines are not independent of each other and they interact on multiple levels. In particular, the GCs that were classically viewed as anti-inflammatory could have a dual role, inducing pro-inflammatory effects. Their administration results in an increased systemic trafficking of lymphocytes and monocytes ([@B10]), and the exertion of pro-inflammatory actions through synergistic interactions with inflammatory cytokines, such as IL-1β and IL-6 ([@B50]; [@B25]; [@B11]).

The mechanisms underlying low-grade systemic inflammation in several organs in the absence of overt infection that was observed during aging are still speculative, and little is known about the "master" molecule involved in this process. The Wild type p53-Induced Phosphatase-1 (WIP-1) is a phosphatase whose expression is induced in response to many types of cellular stress, as γ or UV radiation in a p53-dependent manner ([@B31]). This protein has been associated with cellular senescence ([@B76]), and its expression has been showed to decrease during age ([@B97]). More recently, WIP-1 has been recognized as an intrinsic negative regulator of inflammatory response in the CNS ([@B90]), and also at the peripheral level where it acts as a negative regulator for neutrophil migration and pro-inflammatory cytokines production through various pathways, including the feedback regulation of the NF-κB signaling ([@B87]). It could be hypothesized that WIP-1 could be associated with sterile inflammation that underlines the aging process.

The above mentioned age-related modulations and variations are dynamic and not irreversible processes. The ways that allow modulation of brain plasticity in animal and human using cognitive or physical training have resulted to be of great interest ([@B20]). Several studies on rodents have shown that Environmental Enrichment (EE) -- modification of the environment to enhance the animal physical and psychological well-being -- ([@B5]), has been shown to slow down neuronal aging ([@B49]), improve cognition and memory ([@B47]; [@B41]). Some EE stimuli are able to affect C ([@B79]), cytokines and various immune components at a peripheral level, suggesting that this could be a potential mechanism of action in how it could modulate the brain function ([@B80]). To this end, within cognitive training procedures, Memory Training (MT) based research generally reveals an improvement in memory performance in older adults through the utilization of mnemonic strategies. However, even cognitive training was successfully included within EE stimuli. To our knowledge, neither study has been carried out to determine whether it reduces the endogenous C levels and the behavioral sequence of chronic inflammatory conditions that characterize the aging phenotype.

Considering the above mentioned in aggregate, we hypothesize that the MT could be considered as a treatment that similar to other stimuli of the EE, could enhance the cognitive and physical well-being of older adults. It is for this reason that this study wants to investigate whether a MT program acts on the plasmatic level of C, the pro-inflammatory cytokines IL-6, IL-1β, and L-18, and the expression of the WIP-1 in *ex vivo* Peripheral Blood Mononuclear Cells (PBMCs) of apparently healthy elderly (older adults, 65--74 years; [@B21]), relating to their degree of cognitive abilities. We chose these cytokines because all of them had been previously associated with specific features of aging phenotype ([@B34]), and also their higher levels had been successfully suggested as a marker of poorer cognitive performance in healthy subjects for the IL-6 and the IL-1β ([@B100]), and in a clinical population for the IL-18 ([@B9]; [@B103]).

Our results provide important evidence that MT could contribute to the decreasing of the C level, restore the WIP-1 expression and reduce the value of the pro-inflammatory cytokines at a peripheral level, participating in "holding off" the systemic inflammatory condition that characterizes healthy older adults. We first involved WIP-1 deficiency in the pathophysiology of aging.

Materials and Methods {#s1}
=====================

Participants
------------

Participants of the study were 62 apparent healthy older adult volunteers (29 female, age range 65--74 years of age), recruited with the use of posters, pamphlets and word of mouth at recreational clubs. Thirty-one apparent healthy young adults (16 female, age 19--28 years of age), were also recruited by word of mouth and with pamphlets at University G. d'Annunzio, CH-PE, Italy. The exclusion criteria regarding all participants were summarized in **Table [1](#T1){ref-type="table"}**.

###### 

Exclusion criteria of all participants.

  Exclusion criteria
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  • Body Mass Index (\<20 and \>33 kg/m^2^)
  • Erythrocyte Sedimentation Rate (\<20 mm/hr for males; \<30 mm/hr for females)
  • C Reactive Protein (\<5 mg/L)
  • Hematological and Biochemical Analyses Values within Normal Range
  • Unusual Dietary Habits (e.g., vegetarians)
  • Recent infections, allergies, present or past autoimmune disorders
  • Diagnosis of or treatment for pathological diseases (cancer, diabetes, insufficient renal and hepatic performance, mal-absorption and chronic inflammatory pathologies)
  • Current medication (including herbal remedies or vitamins)
  • Smoking
  • Alcohol consumption (1 week the sample collection, \>30 g/d for men and \>20 g/d for woman)

Briefly, subjects with the BMI \< 20 and \>33 k/m^2^ were excluded ([@B92]; [@B58]). Subjects with unusual dietary habits (e.g., vegetarians) were also excluded ([@B88]). Hematological and biochemical tests needed to be within the normal range. Negative serologies for the HIV and Hepatitis C viruses were verified. To assess the inflammatory status, all recruited subjects underwent the same laboratory blood tests: Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) were measured as non-specific markers for inflammation and were utilized as exclusion criteria. The upper limit of the ESR is 20 mm/hr, for males, and 30 mm/hr for females ([@B81]; [@B13]). To avoid the inclusion of subjects in an acute phase of inflammation (e.g., infection, trauma and tissue necrosis, malignancies, and autoimmune disorders), the subjects with CRP levels \> 5 mg/L were also excluded ([@B36]; [@B1]; [@B6]).

Habitual smokers were excluded because this factor has already been significantly marked as a modulator of C level and strong pro-inflammatory ([@B60]; [@B61]). The participants were invited not to consume alcohol starting 1 week before the sample collection, in order to avoid any effects on C and the systemic inflammation levels ([@B77]; [@B65]).

Subjects who had current infections, allergies, or a present and past history of autoimmune disorders, and those on current medication (including herbal remedies or vitamins) such as anti-inflammatory, antiviral agents or immunosuppressive medication that could directly or indirectly affect the systemic inflammatory state were excluded.

Older adults reaching the "exclusion criteria" adapted from the SENIEUR protocol for demographic suitability was excluded from the study ([@B54]). The exclusion criteria for older adults included factors thought to influence the relationship between the cognitive function and chronic inflammation such as the presence of dementia, and depression. Volunteers were invited to a preliminary screening session based on a full medical history and examination including, anthropometric measurements, the assessment of dietary habits, tobacco and alcohol consumption, and screening for cognitive impairment using the Mini-Mental State Examination (MMSE, [@B32]), and the Geriatric Depression Scale (GDS), that provides a screening measure of depressive symptoms in adults over 55 years ([@B99]). All participants had their cognitive functions assessed using a neurocognitive battery of tests as described to follow. The neurocognitive battery was designed in order to evaluate the memory and attention which are frequently affected in older persons. The subjects with depression (score ≥ 11 on the GDS) and subjects with dementia (score ≤ 24 on the MMSE) were excluded.

A total of 94 consecutive older adults (39 female) were invited to participate in the study. Ten subjects (4 female) were excluded as they were smokers; 3 male subjects were excluded because they had elevated ESR values, one female subject for an elevated CRP value. Eight male and 10 female were excluded as they were on medication. In the end, 62 consecutive subjects (of which 66% subjects contacted) were included in the study. After having signed the consent, 34 subjects were randomly assigned to an Experimental Group (EG) (16 female) and 28 to a Control Group (CG) (13 female) before the cognitive screening assessment.

A total of 43 consecutive young adults (20 female) were invited to participate in the study. Eight subjects (2 female) were excluded as they were smokers, four (2 female) were excluded as they were on medication. In the end, 31 consecutive subjects (of which 74% of subjects contacted) were included in the study.

The study procedures were described in detail to all participants, a minimum reflection time of 24 h was given before written informed consent was obtained. Participants not having the capacity to consent to research participation and non-Italian-speaking participants (because the inclusion of these participants would have meant not to be able to use standardized assessment techniques) were also excluded from the study.

The study was conducted according to the principles expressed in the Declaration of Helsinki and subsequent revisions and was approved by the Ethics Committee of G. d'Annunzio University, Chieti, Italy.

Characteristic of the Sample
----------------------------

Demographic data of the subjects studied are listed in **Table [2](#T2){ref-type="table"}**, together with BMI value and plasmatic level of CRP.

###### 

Characteristics of older adults at baseline.

  Characteristics     Control Group (*n* = 28) (mean ± SD)   Experimental Group (n = 34) (mean ± SD)   *p*-value
  ------------------- -------------------------------------- ----------------------------------------- -----------
  Age (years)         69.0 ± 8.0                             70.6 ± 7.0                                0.428^a^
  Gender (F)          28 (13)                                34 (16)                                   0.730^b^
  Education (years)   9.4 ± 1.7                              9.6 ± 1.8                                 0.681^a^
  BMI (Kg/m^2^)       26.8 ± 2.7                             27.0 ± 3.0                                0.824^a^
  Plasma CRP (mg/l)   1.7 ± 0.6                              1.6 ± 0.6                                 0.530^a^

a

Unpaired Student

t

-test;

b

Chi-squared test; BMI, Body Mass Index; CRP, C-Reactive Protein.

The CG included 28 subjects (13 women; age, mean ± SD, 69.0 ± 8.0 years). The EG included 34 subjects (16 women; age, mean ± SD, 70.6 ± 7.0 years).

The two groups were not significantly different at the baseline (T0) in terms of age (*p* = 0.428), male/female ratio (*p* = 0.730), BMI (*p* = 0.841), education (*p* = 0.681), and plasma CRP (*p* = 0.530). They did not significantly differ for any neuropsychological scores obtained at the beginning in which all scores were within the normal range. At this period all participants were considered healthy and defined as not suffering from any recent episode that could condition the basal inflammatory level and cognitive performance (i.e., infection and malignancy).

Neuropsychological Test Battery
-------------------------------

Cognitive functioning in CG and EG was measured using a comprehensive neuropsychological test battery at baseline (T0) and after 6 months (T1), 1 day before blood sample collection. For all subjects and controls, the same test administration order was used. The battery was comprised of tests with strong psychometric properties and assessed the following cognitive domains:

Global Assessment of Cognitive Function. MMSE ([@B32]) is the use a psychometric test used to quantify the global cognitive functioning and the cognitive change in population-based longitudinal studies. MMSE consists of a series of questions with the aim of quantifying the global cognitive functioning on a 0--30 scale.

The following instruments were administered (in this fixed order), by a psychologist for the overall assessment of each participant, of which had a duration of approximately 90 min, with breaks provided, as requested by participants:

1.  Global Assessment of Cognitive Function. MMSE ([@B32]) is the use a psychometric test used to quantify the global cognitive functioning and the cognitive change in population-based longitudinal studies. MMSE consists of a series of questions with the aim of quantifying the global cognitive functioning on a 0--30 scale.

2.  The GDS was created specifically for screening depressive symptoms among older populations and has been widely utilized in both clinical and research settings. The GDS-30 comprises 30 questions regarding high and low mood, lack of energy, anxiety, and social withdrawal. Assesses depressive symptoms by means of 30 questions to be answered with 'yes' or 'no'. Each question is weighted with 1 point for a positive answer. The sum of these points defines the final score, ranging from 0 to 30 points. The GDS-30 asks how the person feels currently and how the person has felt during the previous week ([@B99]).

3.  The Rey-Osterrieth Complex Figure Test was used to assess visuo-spatial constructional functions, visuographic memory, and some aspects of planning ([@B73]). The subject was asked to make a copy of a stimulus drawing comprised of a complex design, which was then scored on 18 identifiable details with a maximum score of 36 points possible and a higher score indicating better performance. The subject then drew the figure from memory 5 min later, and again 30 min later.

4.  Memory. The ability to retain and recall verbal information was measured using the Rey Auditory Verbal Learning Test ([@B53]). Participants read a 15-item word list five times and were asked to repeat as many words as they could remember for each time. After 50 times, participants were presented an interference list. Participants were then asked to recall words from the original list. Participants were also asked to recall words from the original list 20 min later.

5.  Attentive Matrices Test (Attentive Test) is a valid instrument to measure selective and sustained attention ([@B84]). It consists of 3 numeric matrices (10 columns of 13 numbers from 0 to 9). The participants are required to check specific target numbers in 45 s for each matrix. There are 1 target in the first matrix, 2 in the second one, and 3 in the third one. The score is assigned giving 1 point for each target correctly found in the 3 matrices (max 60 for all the 3 matrices). The time to complete the 3 matrices is considered as scores too.

6.  Trail Making Test (TMT) provides information on visual search, speed of processing, mental flexibility, selective visual attention and ability to shifting ([@B74]). It consists of two parts (A and B), both consisting of 25 circles distributed over a sheet of paper. In Part A, the circles are numbered 1--25, and the subject should draw lines to connect the numbers in ascending order. In Part B, the circles include both numbers (1--13) and letters (A--L) and the subject should draw lines to connect alternatively numbers and letters in ascending order (i.e., 1-A-2-B-3-C). The subject should be instructed to connect the circles as quickly as possible, without lifting the pen or pencil from the paper. Errors should be pointed out immediately and subjects should be allowed to correct it. Time required to complete each of the two parts is recorded, considered as scores of the test.

Memory Training
---------------

The participants of EG were submitted to MT from T0 to T1. The MT is based on the concept that repeated practice within a specific domain results in gains in both cognitive and behavioral efficiency of the targeted domain, as well as subsequently transferring improvements to untrained domains.

The intervention was conducted in several laboratories. All sessions lasted 1 h and were held twice a week, with a total of 48 laboratories (**Figure [1](#F1){ref-type="fig"}**).

![Flow chart of the Memory Training Program.](fnmol-10-00233-g001){#F1}

During MT, two different mnemonics were used. To assess the EG visual mnemonic (Loci) and general strategies (Strategic) were used ([@B14]). The Loci mnemonics is based on participants that generate sequences of visuo-spatial images of familiar locations, and further produce an image that is more complex, with the initial scene and the name/object to remember. The second training was characterized by the use of disparate strategies in different situations and each of them required a special strategy (generating mental images, association or categorization of items).

Older adults are particularly sensitive to the setting and emotional conditions. For this reason, we used ecological tasks to reproduce daily activities ([@B2]).

Story recall. All participants had 5 min to study a short story composed of 22 units. They then had to write what they remembered. Performance was assessed according to the correct number of units they could remember.

Shopping list recall. A shopping list was read to all the participants and they had 5 min to remember and subsequently put it in writing. Performance was evaluated according to the correct number of products which were remembered.

Memory for faces/names. Twelve photographs, each coupled with a name, on a computer screen was presented to all participants for 30 s. The same faces, were then shown without names and participants had to remember the names. Performance was assessed according to the correct face/names associations made.

Memory for places. A map of an Italian city with the name and the position of 10 monuments was presented to all participants for 5 min. They then had to remember and to write the name and the position of the monuments on a blank map. Performance was evaluated according to the correct names and positions which were remembered ([@B14]).

Cell Sources and Cultures
-------------------------

Blood samples were collected at T0 and T1. Veni-puncture was performed in the morning between 08.00 and 10.00 am. in order to avoid the effect of diurnal variation, and peripheral blood samples were collected in 4 ml endotoxin-free Heparin tubes (Vacutainer, Becton Dickinson, NJ, United States). Tubes were kept at room temperature and transported to the laboratory for processing within 1 h of collection. The plasma was obtained by blood centrifugation as described previously and was kept frozen at -20°C ([@B71]).

The PBMCs were isolated as described previously and used freshly for the evaluation of the WIP-1 mRNA and protein expressions and for the study of NF-kB signaling ([@B83]). Briefly, the PBMCs were isolated by density-gradient centrifugation through Ficoll-Hypaque (Pharmacia), suspended (10^6^/ml) in RPMI 1640 medium (Sigma-Aldrich, St Louis, MO, United States), containing [L]{.smallcaps}-glutamine 1% and antibiotics (penicillin 100 U/ml-streptomycin 100 ug/ml) with 10% heat-inactivated fetal calf serum (Sigma, CA, United States), seeded in polypropylene tubes (Falcon, BD, Lincoln Park, NJ, United States) and incubated at 37°C in a 95% humidified 5% CO~2~ cell culture incubator. Cell viability in each culture was assessed by Trypan blue die exclusion. All solutions were prepared using pyrogen-free water and sterile polypropylene plastic-ware and were free of detectable LPS (\<0.1 EU/ml), as determined by the Limulus amoebocyte lysate assay (sensitivity limit 12 pg/ml; Associates of Cape Cod, Falmouth, MA, United States). All reagents used were tested before use for Mycoplasma contamination (minimum detection level 0.1 μg/ml) (Whittaker Bioproducts, Walkersville, MD, United States) and found negative. The same batches of serum and medium were used in all experiments. After 24 h incubation, samples were centrifuged at 400 × *g* for 10 min at room temperature, supernatants were collected and stored at -80°C pending assay ([@B72]). The PBMCs yield per mL of blood was approximately 1 × 10^6^ cells.

RNA Extraction and the Quantitative Real-Time Polymerase Chain Reaction (qPCR) System
-------------------------------------------------------------------------------------

Total RNA was extracted from PBMCs of all subjects using the TRIzol reagent (Invitrogen, Life Technologies, Paisley, United Kingdom) according to the manufacturer's protocol. The RNA concentration and purity were determined by measuring absorbencies at 260 and 280 nm; a 260:280 ratio of 1.9 being considered acceptable for analysis. The RNA concentration was estimated by measuring the absorbance at 260 nm using a Bio-Photometer (Eppendorf AG, Hamburg, Germany), and RNA samples were kept frozen at --80°C until use. Purified RNA was electrophoresed on a 1% agarose gel to assess the integrity of the purified RNA. The RNA yield was 8.2 ± 2.7 μg/10^6^ cells (mean ± SD).

Before Reverse Transcription, residual genomic DNA was removed from Total RNA using DNaseI (Thermo Scientific). The reaction mix was as follows: 1 μg of Total RNA, 1 μl of 10x Reaction Buffer, 1 U of DNaseI and water up to 10 μl. The mix was incubated at 37°C for 30 min and stopped by adding 1 μl of EDTA 50 mM and incubating at 65°C for 10 min. A High Capacity cDNA Reverse Transcription kit (Applied Biosystem) was used for reverse transcription of mRNAs. The reaction mix was prepared as follows: 2 μg of total RNA, 2 μl of 10x RT Buffer, 0.8 μl of dNTP, 2 μl of 10x Random Hexamer, 50 U of MultiScribe Reverse Transcriptase, 1 μl of RNase Inhibitor and water up to 20 μl. cDNA synthesis was performed in a thermal block cycler (Bio-rad) following these steps: priming at 25°C for 10 min, transcription at 37°C for 120 min and enzyme inactivation at 85°C for 5 min. All cDNA samples were stored at -20°C pending qPCR analysis.

A qPCR assay was carried out in an Eppendorf Mastercycler EP Realplex (Eppendorf AG). Briefly, preliminary PCR reactions were run to optimize the concentration and ratio of each primer set. For all the cDNA templates 2 μL was used in a 20 μL qPCR amplification system of the SYBR Green Real Master Mix Kit. Primers for human WIP-1 gene and GAPDH as reference gene were designed using GeneWorks software (IntelliGenetix, Inc., Mountain View, CA, United States).

The primer pairs used were as follows: WIP-1 (NM003620) forward-5′-TTTTTATATTGTTTTTAGGTTATT-3′ and reverse-5′-ATCTATATAAACTTTTAACTCAATC-3′; GAPDH (NM002046) forward-5′-ACCACCATGGAGAAGGC-3′ and reverse-5′-GGCATGGACTGTGGTCATGA-3′. The amplification procedures and data computation followed were similar to those described above ([@B70]). In this study stability of GAPDH did not vary in the cells whatever the conditions. Thus, the relative expression of WIP-1 was normalized to GAPDH using the ΔC~q~ method \[relative expression = 2^-ΔCq^, where ΔC~q~ = C~q(WIP1)~ -- C~q(GAPDH)~\].

Western Blotting
----------------

Peripheral Blood Mononuclear Cells were washed once in cold phosphate-buffered saline (PBS; 0.5 mol/L sodium phosphate, pH 7.5), harvested by gentle scraping, and used to prepare total or nuclear protein extracts. Total protein extracts were prepared as described previously by treating cells with lysis buffer for 30 min at 4°C ([@B29]). Nuclear extracts were prepared as previously described ([@B82]). The protein concentrations of the extracts were determined using the Bradford method (Bio-Rad protein assay, Hercules, CA, United States).

For Western blotting (WB) analysis, 50 μg of protein per lane was separated on a 4-12% NuPAGE gradient gel (Gibco Invitrogen), electrotransferred onto a nitrocellulose membrane and blocked with 10% skimmed milk in PBS containing 0.1% Tween-20 ([@B33]). Blots were probed and incubated overnight at 4°C with polyclonal rabbit IgG anti-WIP1, and pNF-κB (p-p65^Ser536^) (Santa Cruz Biotechnology, Santa Cruz, CA, United States), all at 0.2 μg mL^-1^ in Tris-buffered saline (TBS)/0.1% Tween-20. A mouse antihuman monoclonal antibody recognizing human β-actin (A5441; Sigma--Aldrich) was used as the control in all experiments. A rabbit antihuman antibody for β-tubulin was used as the control in experiments with nuclear extract proteins (Santa Cruz Biotechnology, Santa Cruz, CA, United States). Three microgram of human recombinant the WIP-1 protein was used as positive control (Lifespan Biosciences, Seattle, WA, United States). Fifty microgram of nuclear extract proteins from PBMCs previously treated with the LPS (10 μg/mL) and INFγ (20 ng/mL) was used as positive control for the detection of p-p65^Ser536^ ([@B71]).

Blots were then washed and incubated for 1 h with goat antirabbit-horseradish peroxidase (Pierce Biotechnology, Rockford, IL, United States) diluted 1:10000 in TBS/0.1% Tween-20. Immunoblot signals were developed using Super Signal Ultra chemiluminescence detection reagents (Pierce Biotechnology). The blot images were analyzed by a gel analysis software package (Gel Doc 1000; Bio-Rad, Milan, Italy). Data are expressed as the mean ± SD intensity of optical density.

Role of WIP-1 in Regulating NF-kB Signaling
-------------------------------------------

In order to detect the role of the WIP-1 in regulating NF-κB signaling, the PBMCs were isolated and cultured during the study, as above described. The cultured cells were pre-treated or not treated with the WIP-1 inhibitor GSK2830371 for 1 h, and later the cells were stimulated with the LPS and INFγ. The LPS was used at 10 μg/mL, IFNγ at 20 ng/mL, and GSK2830371 at 10 μM (Sigma--Aldrich, St Louis, MO, United States) ([@B71]).

Plasma Sampling and Measurement of C, CRP, IL-1β, IL-18, and IL-6 Levels, and *In Vitro* Production of Cytokines
----------------------------------------------------------------------------------------------------------------

Plasma was obtained with blood centrifugation at 1500 × *g* for 7 min and kept frozen at -20°C from all participants. The amount of plasma circulating IL-1β, IL-18, IL-6, C, and the CRP was assayed with the use of specific ELISA development systems (Pierce, Rockford, IL, United States) in all individuals. The amount of IL-1β, IL-18, IL-6 from the culture supernatants of the PBMCs was assayed with the use of specific ELISA development systems (Pierce, Rockford, IL, United States) in older adults after 6 months of being on a MT program. The experiments were performed according to the manufacturer's instructions.

Plates were scanned using a specialized Charge Coupled Device cooled tool. The integrated density values of the spots of known standards were used to generate a standard curve. Density values for unknown samples were determined by using the standard curve for each subject in order to calculate the real values in pg/mL. All steps were performed in duplicate and at room temperature. The IL-1β assay sensitivity was ≤1.0 pg/ml, for IL-18 it was ≤12.5 pg/mL, for IL-6 it was ≤1 pg/ml, for C it was ≤56.7 pg/mL, and for CRP ≤ 10.0 pg/ml. The values below the assay sensitivity have been excluded. The intra- and inter-assay reproducibility was \>90%. Duplicate values that differed from the mean by more than 10% were considered suspect and were repeated.

Statistical Analysis
--------------------

The normal distributions of data were tested by the Skewness and Kurtosis measurement. All the variables considered, resulted distributed in a normal manner. The results were reported separately for each group: young adults, total older adults, older adults Control Group (CG) and older adults Experimental Group (EG). The Unpaired Student *t*-test was used to assess significant differences between the young group and total older adults. The unpaired Student *t*-test and Chi-squared test were applied to evaluate significant differences between the CG and the EG. The same statistical test was applied to evaluate the differences for biological variables. Pearson's (r) co-efficient correlation was applied to assess the strength of the relationship between the basal levels of age, BMI, WIP-1, C, IL-1β, IL-18, IL-6, CRP and of the MMSE scores in older adult subjects. In order to assess the multi-collinearity of the variables, the diagnostic factors, Tolerance and Variance Inflation Factor (VIF) were considered. Accordingly, the MMSE scores were used as an dependent variable in a multiple regression analysis, whereas Age, as well as C, WIP-1, IL-1β, IL-18, and IL-6 were used as independent ones. The differences pre- and post-cognitive training were analyzed by the Paired samples *t*-test. Statistical analyses were performed using the SPSS 19.0 statistic (SPSS Inc., Chicago, IL, United States) for Windows (IBM). Results are described as means ± SD for each assessment performed in triplicate. All statistical tests were two-tailed and were evaluated at an alpha level of 0.05.

Results
=======

The Relationship between Global Cognitive Functioning and Biological Variables in Older Adults
----------------------------------------------------------------------------------------------

**Table [3](#T3){ref-type="table"}** shows the bivariate correlations at T0 between Age, BMI, the plasmatic level of C, CRP, the pro-inflammatory cytokines IL-1β, IL-18, IL-6, the mRNA expression of the WIP-1 from *ex vivo* PBMCs, and MMSE score of all older adults (*n* = 62).

###### 

Pearson (r) correlation between Age, Body Mass Index (BMI), Mini Mental State Examination (MMSE) score, Cortisol (C) and immune markers at baseline in apparently healthy older adults (*n* = 62).

          BMI       MMSE         C             WIP1          IL-1β         IL-18         IL-6          CRP
  ------- --------- ------------ ------------- ------------- ------------- ------------- ------------- ---------
  Age     --0.235   --0.303^∗^   0.345^\#^     --0.368^\#^   0.320^∗^      0.371^\#^     0.327^∗^      0.013
  BMI     \_        0.032        0.043         0.147         0.190         0.034         0.254^∗^      --0.136
  MMSE              \_           --0.340^\#^   0.322^\#^     --0.298^∗^    --0.324^\#^   --0.296^∗^    --0.024
  C                              \_            --0.299^∗^    0.272^∗^      0.363^\#^     0.252^∗^      0.161
  WIP-1                                        \_            --0.426^\#^   --0.660^\#^   --0.505^\#^   0.158
  IL-1β                                                      \_            0.463^\#^     0.426^\#^     --0.188
  IL-18                                                                    \_            0.340^\#^     --0.189
  IL-6                                                                                   \_            --0.206

WIP-1, Wild type p53-induced phosphatase 1; IL, Interleukin; CRP, C-reactive protein.

∗

p

\< 0.05;

\#

p

\< 0.01.

The Age parameter correlated significantly as well as negatively with the WIP-1 mRNA expression (*r* = -0.368, *p* \< 0.01), whereas it correlated positively with the IL-1β (*r* = 0.320, *p* \< 0.05), the IL-18 (*r* = 0.371, *p* \< 0.01), and the IL-6 (*r* = 0.327, *p* \< 0.05). The BMI did not correlate with any variable considered, except for the IL-6 (*r* = 0.254, *p* \< 0.05).

The MMSE score correlated positively to the WIP-1 (*r* = 0.322; *p* \< 0.01), and negatively to C (*r* = 0.340; *p* \< 0.01) and to all the pro-inflammatory cytokines analyzed. Once again, the plasmatic level of C at baseline was significantly as well as negatively associated to the WIP-1 mRNA expression, and positively associated to IL-1β, IL-18, and IL-6. The cytokines were strongly and positively associated with each other. None of the variables considered, correlated significantly with the CRP.

The correlation values obtained at T0 were not confirmed at T1 for Age and the MMSE score, Age and C, and Age as well as immune markers evaluated. The same significant loss also occurred when the correlation were analyzed for the EG at T1.

**Table [4](#T4){ref-type="table"}** presents the multiple linear regression analysis results. The MMSE score was considered as a dependent variable. The variables which show significant correlation vs. MMSE score were considered as potential independent variables for the analysis. In order to assess multi-collinearity, the diagnostic factors, Tolerance and VIF were evaluated. As a consequence, none of the variables were excluded. The analysis was carried out using Age, C, WIP-1, IL-1β, IL-18, and IL-6 as independent variables that were added stepwise. The model including Age, C, and amount of the WIP-1 mRNA in *ex vivo* PBMCs resulted as the most significant, accounting for 13.4% of the MMSE variance \[*F*~(1,60)~= 4.105; *p* = 0.010\] (Supplementary Table [1](#SM1){ref-type="supplementary-material"}).

###### 

Regression analysis summary for biological variables predicting cognitive function.

  Dependent variable   Independent variables              *R*^2^   *R*^2^ adjusted   *F*     ANOVA (*p*)
  -------------------- ---------------------------------- -------- ----------------- ------- -------------
  MMSE score           Age                                0.085    0.069             5.478   0.023
  MMSE score           Age, C                             0.147    0.117             4.986   0.010
  MMSE score           Age, C, WIP1                       0.178    0.134             4.105   0.010
  MMSE score           Age, C, WIP1, IL-1β                0.193    0.135             3.342   0.016
  MMSE score           Age, C, WIP1, IL-1β, IL-18         0.194    0.121             2.655   0.032
  MMSE score           Age, C, WIP1, IL-1β, IL-18, IL-6   0.207    0.119             2.347   0.044

The MMSE score was regressed on Age, Cortisol (C), Wild type p53-induced phosphatase 1 (WIP-1), IL-1β, IL-18, IL-6 in an stepwise regression analysis (

n

= 62). All variables were considered at baseline. IL, Interleukin.

Neuropsychological Test
-----------------------

Cognitive functioning was directly assessed using a neuropsychological test battery. In 62 apparent older adults, the global cognitive function was measured by the MMSE at T0, and after 6 months of the MT program (T1). At the same time, verbal memory was assessed to measure the ability to retain (Short Term Memory, STM) and recall (Long Term Memory, LTM) verbal information using the RAVL Test. Visual memory was evaluated through the ROCF Test. Attention was assessed by the TMT A, the TMT B and the test of Attentive Matrices.

The results reported in **Table [4](#T4){ref-type="table"}** show that the MMSE score significantly increased at T1 in EG when compared to their baseline score (28.3 ± 1.6 vs. 26.1 ± 1.7, *p* \< 0.01). We also observed that the MMSE score of EG at T1 was significantly higher than those of CG (28.3 ± 1.6 vs. 26.4 ± 1.9, *p* \< 0.01).

With close attention, we observed significant differences pre- and post- the MT program for attentive test targets. The medium number of targets attempted was augmented in the EG over time (48.8 ± 6.2 vs. 55.7 ± 5.1, *p* \< 0.05), and between the EG and the CG at T1 (55.7 ± 5.1 vs. 50.2 ± 5.0, *p* \< 0.05). The two groups did not differ significantly in their TMT A (*p* = 0.611) or TMT B (*p* = 0.684) performance concerning completion time at T0. However, the completion time was different between the two groups at the T1, in which it was lower in the EG both for the TMT A (35.1 ± 8.1 vs. 42.2 ± 11.5, *p* \> 0.05), that the TMT B (66.2 ± 20.7 vs. 78.9 ± 27.7, *p* \> 0.05), but it did not reach the significance. The EG did not show significant variation of scores when compared to themselves at T0 for the TMT A (35.1 ± 8.1 vs. 41.8 ± 10.5, *p* \> 0.05), and B (66.2 ± 20.7 vs. 79.3 ± 28.4, *p* \> 0.05). We again found that the RAVLT score followed the same trend over time observed in the EG for global cognitive assessment. In detail, the STM score significantly increased from 2.5 ± 1.2 to 3.4 ± 1.0 (*p* \< 0.01), and the LTM significantly improved from 2.3 ± 1.2 to 3.3 ± 1.2 (*p* \< 0.01). We did not observe any variation over time in the CG. Nonetheless, the EG showed a significantly higher RAVLT score for the STM at T1 when compared to CG, whereas the groups did not differ significantly for STM and for any neuropsychological measure at the baseline (**Table [5](#T5){ref-type="table"}**).

###### 

Neuropsychological assessment of global cognitive function, attention, verbal and visual memory from a Control Group (CG) and from an Experimental Group (EG) at baseline (T0) and also after 6 months of a Memory Training Program (T1).

  Neuropsychological tests   CG-T0 (*n* = 28) (mean ± SD)   EG-T0 (*n* = 34) (mean ± SD)   CG-T1 (*n* = 28) (mean ± SD)   EG-T1 (*n* = 34) (mean ± SD)
  -------------------------- ------------------------------ ------------------------------ ------------------------------ ------------------------------
  Dementia (MMSE)            26.7 ± 1.7                     26.1 ± 1.7                     26.4 ± 1.9                     28.3 ± 1.6^a,b^
  **TMT**                                                                                                                 
  Part A (s)                 41.3 ± 12.5                    41.8 ± 10.5                    42.2 ± 11.5                    35.1 ± 8.1
  Part B (s)                 78.1 ± 29.0                    79.3 ± 28.4                    78.9 ± 27.7                    66.2 ± 20.7
  AM (targets)               48.2 ± 5.4                     48.8 ± 6.2                     50.2 ± 5.0                     55.7 ± 5.1^a,b^
  **RAVLT**                                                                                                               
  STM                        2.6 ± 1.5                      2.5 ± 1.2                      2.7 ± 1.3                      3.4 ± 1.0^a,b^
  LTM                        2.8 ± 1.1                      2.3 ± 1.2                      2.6 ± 1.3                      3.3 ± 1.2^a,b^
  **ROCF**                                                                                                                
  Copy                       26.8 ± 7.1                     27.2 ± 8.2                     27.5 ± 9.3                     32.4 ± 5.8^a,b^
  Delayed recall             12.4 ± 5.1                     11.8 ± 5.0                     13.2 ± 7.8                     14.4 ± 3.8^a,b^

The MMSE was used to quantify global cognitive functioning and cognitive change over time. The Attentive Matrices Test (AM) was used to measure selective and sustained attention (max targets = 60). The Trail Making Test (TMT) (Part A and Part B) provides information on visual search, the speed of processing, mental flexibility, selective visual attention and the ability of shifting. The score is represented by the time spent on test completion. The ability to retain (Short Term Memory, STM) and recall (Long Term Memory, LTM) verbal information was measured using the Rey Auditory Verbal Learning Test (RAVLT). The Rey-Osterrieth Complex Figure (ROCF) Test was used to assess visuo-spatial constructional functions, visuo-graphic memory, and a few planning aspects.

a

p

\< 0.05 vs. CG at the same time (Unpaired Student

t

-test);

b

p

\< 0.05 vs. themselves at T0 (Paired

t

-test).

The data obtained for Visual memory through the ROCF Test, suggested that the MT program also significantly improved this function in subjects of the EG over time. We did not observe any difference between groups at the T1 (**Table [5](#T5){ref-type="table"}**).

Age Dependent WIP-1 mRNA and Protein Expression
-----------------------------------------------

The expression of WIP-1 has been shown to decrease during aging in murine model ([@B97]). In order to confirm on human the differentiated expression of the WIP-1 during age, qPCR, and WB experiments were performed to detect the mRNA and protein level, respectively, on freshly isolated PBMCs from healthy young and older adults. The results showed in **Figure [2](#F2){ref-type="fig"}**, suggest that older adults were characterized by significantly lower levels of the WIP-1 expression.

![Wild type p53-induced phosphatase 1 (WIP-1) expression levels in freshly isolated Peripheral Blood Mononuclear Cells (PBMCs) from Young and Older adults at baseline. **(A)** mRNA was quantified using qPCR in Young adults (*n* = 31) and Older adults (*n* = 62). Sequence-specific primers to the WIP-1 gene were used to quantify the expression of WIP-1 promoter. Values are expressed as relative expression to GAPDH as the reference gene. Values are means ± SD of three experiments performed in triplicate. **(B)** WIP-1 protein expression in PBMCs from Young adults as compared to Older adults at T0. Top, representative Western blot image of WIP-1 and β-actin. Bottom, each immunoreactive band was analyzed by densitometry and normalized to β-actin levels. Each value is a mean ± SD of three different experiments performed in triplicate. ^∗^*p* \< 0.05 vs. older adults.](fnmol-10-00233-g002){#F2}

Memory Training Modulation on WIP-1 mRNA and Protein Expression
---------------------------------------------------------------

We determined the expression of the WIP-1 mRNA transcripts in freshly isolated PBMCs from selected healthy older adults by the qPCR at the baseline and after 6 months of the MT program in the CG and in the EG. **Figure [3A](#F3){ref-type="fig"}** shows the results from subjects of both groups. Compared with the CG, the PBMCs obtained from the EG were found to contain much higher levels of the mRNA for the WIP-1 at T1, determined as its expression relative to the reference gene GAPDH obtained from all subjects at each time. We did not observe any difference between groups at T0. Nevertheless, the WIP-1 mRNA expression was significantly higher in the PBMCs of the EG at T1 when compared to their value at the baseline. In detail, the detected amount of the WIP-1 mRNA in PBMCs from subjects of the EG at T1, is increased by more than 40% when compared to the EG at T0, and the CG at T1.

![Wild type p53-induced phosphatase 1 expression levels in freshly isolated PBMCs from Control Group (CG) and Experimental Group (EG) at baseline and after 6 months of memory training program. **(A)** mRNA was quantified using qPCR in CG (*n* = 28) and EG (*n* = 34). Sequence-specific primers to the WIP-1 gene were used to quantify the expression of WIP-1 promoter. Values are expressed as relative expression to GAPDH as the reference gene. **(B)** WIP-1 protein expression in PBMCs from EG at T1 as compared to CG and EG at baseline (T0). Top, representative Western blot image of WIP-1 and β-actin. Bottom, each immunoreactive band was analyzed by densitometry and normalized to β-actin levels. Each value is a mean ± SD of three different experiments performed in triplicate. ^∗^ *p* \< 0.05 vs. T0; ^\#^ *p* \< 0.05 vs. CG at the same time.](fnmol-10-00233-g003){#F3}

The levels of the WIP-1 protein in PBMCs were measured by the WB. In accordance with the mRNA levels, the PBMCs from the CG had significantly lower levels of the WIP-1 protein versus the EG after the MT program. The expression of the WIP-1 protein was also significantly increased within the EG over time. According to those reported for the mRNA, the protein level did not significantly differ between groups at T0 (**Figure [3B](#F3){ref-type="fig"}**).

Cortisol, CRP, and Cytokines Production
---------------------------------------

In order to highlight the effects of the MT on the C level and the low-grade of inflammation which characterizes healthy older adults, the ELISA test was used to detect the plasmatic level of C as well as determining the non-specific marker for inflammation CRP in both groups at baseline and after the MT. Significant variation for CRP was not observed. As reported in **Table [6](#T6){ref-type="table"}**, our data suggest that the MT significantly modulates the C plasma level. That level had significantly decreased in the EG at T1 when compared vs. CG at T1 and vs. EG at T0. In order to investigate any involvement of the MT on cytokine production in healthy older adults, the plasma levels of the IL-1β, the IL-18, and the IL-6 were evaluated. **Table [5](#T5){ref-type="table"}** also shows the concentrations of cytokines detected in plasma of both groups at T0 and T1. The levels of the IL-1β, the IL-18 and the IL-6 detected at T0 did not significantly differ between the CG and the EG. On the other hand, the submission to the MT program significantly decreased the plasmatic level of all cytokines analyzed at T1 in the EG. Consequently, the subjects of this group showed a significant decrease over time.

###### 

Time-dependent effect of memory training on Cortisol and the plasmatic pro-inflammatory mediators.

                     CG-T0 (mean ± SD)   EG-T0 (mean ± SD)   CG-T1 (mean ± SD)   EG-T1 (mean ± SD)
  ------------------ ------------------- ------------------- ------------------- -------------------
  Cortisol (pg/mL)   136.2 ± 56.4        134.9 ± 58.2        131.5 ± 67.7        109.3 ± 48.1^a,b^
  IL-1β (pg/mL)      26.1 ± 8.3          25.9 ± 8.7          25.9 ± 7.9          22.8 ± 8.4^a,b^
  IL-18 (pg/mL)      239.2 ± 48.0        241.8 ± 45.1        238.0 ± 41.0        212.1 ± 43.1^a,b^
  IL-6 (pg/mL)       1.41 ± 0.26         1.46 ± 0.26         1.40 ± 0.27         1.23 ± 0.16^a,b^

Cortisol, IL-1β, IL-18, and IL-6 plasma level are expressed as means ± SD (IL-1β, IL-18, and IL-6 CG at T0 and T1,

n

= 28; IL-1β, IL-18, and IL-6 EG at T0,

n

= 34; IL-1β and IL-18 EG at T1,

n

= 34; IL-6 EG,

n

= 31). T0, baseline time; T1, 6 months from the baseline time; CG, Control Group; EG, Experimental Group; IL, Interleukin.

a

p

\< 0.05 vs. T0;

b

p

\< 0.05 vs. CG at the same time.

The Role of WIP-1 in Regulating NF-kB Signaling in PBMCs from Healthy Older Adults
----------------------------------------------------------------------------------

The role of the NF-κB in the expression of pro-inflammatory cytokines has been broadly reviewed ([@B18]). The post-translational modification of the NF-κB (p65) affects its transcriptional activity; in particular, several reports have documented negative regulation of the NF-κB by the WIP-1, also through the direct dephosphorylation of Ser-536 of p65 ([@B17]). We next further performed WB studies to determine the phosphorylation of p65 at Ser-536, using specific phospho-p65 antibody on nuclear protein extracts. In the EG, we observed a down-regulation of nuclear translocation of the p-p65^Ser536^ as compared to the CG group at T1. As a result, the phosphorylated p65 in the EG showed low levels at T1 when compared to their own levels at T0 (**Figure [4A](#F4){ref-type="fig"}**).

![Phosphorylated levels of p65 in nuclei of PBMCs of older adults. **(A)** p-p65^Ser536^ protein expression in nuclei of freshly isolated PBMCs from CG and EG at T1 as compared to baseline values (T0). Top, representative Western blot image of p-p65^Ser536^. **(B)** PBMCs from CG and EG were cultured and then treated with WIP-1 inhibitor (GSK 2830371, 10 μM), LPS (10 μg/ml) + INFγ (20 ng/ml) or WIP-1 inhibitor and LPS (10 μg/ml) + INFγ (20 ng/ml), as described in "Materials and Methods" Section. Western immunoblotting was performed on nuclear proteins with antibody anti-p-p65^Ser536^ and anti-β-tubulin as the control. The image represents six different gels performed twice. Values are expressed relative to control (mean ± SD). ^a^*p* \< 0.05 vs. CG; ^b^*p* \< 0.05 vs. EG at T0; ^c^*p* \< 0.05 vs. control PBMCs; ^d^*p* \< 0.05 vs. PBMCs treated with LPS and INFγ.](fnmol-10-00233-g004){#F4}

In order to better investigate the role of this phosphatase in regulating the NF-κB nuclear translocation, the PBMCs from the CG and the EG at T0 and T1 were cultured and treated with a selective inhibitor of the WIP-1 (GSK 2830371) and/or LPS + INFγ, while nuclear protein extracts were detected by an antibody specific for the p-p65. As shown in **Figure [4B](#F4){ref-type="fig"}**, treatment with the LPS + INFγ increased the p-p65^Ser536^ expression in nuclei. This response was significantly elevated in the PBMCs from the CG as compared to the EG at T1. It should also be noted that the WIP-1 inhibition resulted in a significant increase in the constitutive and the LPS + INFγ-induced p65 phosphorylation and nuclear translocation in both groups. These findings suggested that the WIP-1 expression is significantly involved in the negative regulation of the NF-κB activity.

Furthermore, the inhibition of the activity of the WIP-1 resulted in a significantly higher constitutive and induced the release of the IL-1β, of the IL-18 and of the IL-6 in the medium of cultured cells (**Table [7](#T7){ref-type="table"}**). We did not observe any significant differences between cells treated with an inhibitor and a medium alone, either in the p-p65^Ser536^ nuclear levels (**Figure [4B](#F4){ref-type="fig"}**) or in cytokines release (**Table [7](#T7){ref-type="table"}**).

###### 

Comparison of the IL-1β, of the IL-18, and of the IL-6 release in conditioned medium by non-stimulated and the LPS + INFγ and/or WIP-1 inhibitor (GSK2830371, 10 μM) treated Peripheral Blood Mononuclear Cells (PBMCs) (pg/ml/10^6^ cells) from 28 subjects of Control Group (CG) and 34 of the Experimental Group (EG) after 6 months of being on a Memory Training Program (T1).

          Control (pg/mL, mean ± SD)   WIP-1 inhibitor (pg/mL, mean ± SD)   LPS/INFγ (pg/mL, mean ± SD)   LPS/INFγ + WIP-1 inhibitor (pg/mL, mean ± SD)                                                   
  ------- ---------------------------- ------------------------------------ ----------------------------- ----------------------------------------------- -------------- ----------------- -------------- -------------------
  IL1β    9.7 ± 4.2                    5.6 ± 3.1^a^                         35.9 ± 4.4                    22.4 ± 6.2^a,b^                                 398.2 ± 37.4   321.4 ± 25.4^a^   512.0 ± 58.7   380.6 ± 54.8^a,b^
  IL-18   36.9 ± 5.4                   26.2 ± 6.1^a^                        76.1 ± 6.8                    51.7 ± 14.4^a,b^                                282.6 ± 18.7   212.6 ± 16.1^a^   371.2 ± 22.2   324.1 ± 31.5^a,b^
  IL-6    128.7 ± 25.4                 94.1 ± 18.9^a^                       156.2 ± 26.6                  135.8 ± 19.2^a,b^                               213.8 ± 22.7   178 ± 28.1^b^     244.6 ± 32.3   212.8 ± 0.3^a,b^

Supernatants were collected, stored at -80°C until analysis, and then measured for IL-1β, IL-18, and IL-6 concentration using a commercial enzyme-linked immunosorbent assay (ELISA). All samples for a given assay were analyzed in duplicate at the same time. The ELISA values have an error range lower than 10%. The variation coefficient both inter-assay and intra-assay was \<5%.

Values are presented as means ± SD.

a

p

\< 0.05 vs. respective CG;

b

p

\< 0.05 vs. respective WIP-1 inhibitor no treated cells.

Altogether, these findings suggest a role for the WIP-1 activity in mediating the NF-κB nuclear levels and pro-inflammatory cytokines released in older adults. Furthermore, the submission to 6 months of the MT significantly restored the WIP-1 inhibitory function.

Discussion
==========

In the current study, we assume that the MT through mnemonic strategies could be considered as treatment that similarly to other stimuli of the EE, could enhance the cognitive and physical well-being of older adults. We studied a sample of apparently healthy older adults and used a longitudinal approach to test the hypothesis that the MT program could counteract the higher level of plasmatic C and sterile inflammation that characterizes adulthood as well as a decline in the cognitive function. We also investigated whether the phosphatase WIP-1 in *ex vivo* PBMCs could be considered a "master" molecule involved in modulating the level of plasmatic pro-inflammatory cytokines IL-6, IL-1β, and IL-18.

Concerning our correlation's data, the associations recorded between cytokines, Age, MMSE score and mRNA of WIP-1 suggested a role of this phosphatase in the inhibition of the release of the IL-6, the IL-1β, and the IL-18. We first purposed a significant connection between global cognitive functioning and the IL-18 in healthy subjects, and highlighted a previously unrecognized relationship between plasmatic C levels and immune markers analyzed. Our results again reinforced the positive correlation between Age and C, as well as the negative association between the global cognitive function and C ([@B12]; [@B67]). Worth noting is that in a linear regression analysis, Age, C, and the WIP-1 mRNA expression resulted as the best predictors of variance in global cognitive performance and explained approximately the 13% variance in the MMSE score. We were in accordance with previous findings suggesting positive association between the cytokines measured and Age ([@B24]; [@B63]), and the IL-6 and BMI ([@B64]). We also agree with other authors in observing any significant association between the CRP plasmatic level and global cognitive functioning ([@B27]).

As far as MT is concerned, accordingly with other studies, our results highlight better performance relating to verbal and visuo-spatial memory after 6 months of laboratory participation. Interestingly, as suggested by a significant decrease in the completion time of attentive matrices, MT contributes to attention performance enhancement. In regards to this, we are in line with the assumption that working memory used effectively is necessary to continuously select what is being represented by paying major attention to the way in which the working memory functions, and to update what is represented according to the relevance of the task ([@B69]).

Cognitive improvement was paralleled over time by the lowering of the plasmatic level of the glucocorticoid hormone C, and by a significant reduction in the plasmatic levels of the pro-inflammatory cytokines evaluated. These findings suggest a previously unrecognized beneficial effect of the MT program participation, as increased C levels have been associated to several age-related pathologies that include muscle atrophy ([@B26]), osteoporosis/hypercalcemia ([@B46]), hyperglycemia/hyperlipidemia, atherosclerosis, type II diabetes and major depression ([@B7]; [@B52]; [@B4]). The peripheral level of the IL-6 contributes to age-related neural atrophy ([@B96]), it is considered a marker of increased risk of frailty ([@B28]), and is associated with reduced muscle strength ([@B3]) during adulthood. No less important, the circulating levels of the IL-1β and of the IL-18 which are considered detrimental for aging successfully were involved in the mediation of several downstream effects of the NLRP3 inflammasome activation ([@B59]; [@B102]). In particular, the IL-1β is thought to play a predominant role in the development of several age-related degenerative diseases including type 2 diabetes and Alzheimer's Disease (AD) ([@B101]; [@B42]). Both cytokines have been suggested to regulate obesity-induced inflammation, insulin resistance, and plaque instability and atherogenesis ([@B85]; [@B93]; [@B95]; [@B78]).

At the same time, the MT could contribute to generate a positive loop in which memory performance improvement was further sustained by the lowering of the plasmatic level of C and of pro-inflammatory cytokines. In this respect, the higher level of C was related to the parameters of cognitive frailty ([@B12]), and more recently has been directly associated to cognitive performance in a large sample of non-demented subjects aged at least 65 years ([@B68]). Nevertheless, the IL-6 has been associated with poorer performance on tests of encoding and the recall of information and working memory ([@B27]). The concentrations of the IL-1β were extensively related to the negative effects on memory in animal and human studies ([@B100]). To the best of our knowledge, there are no studies that have been previously associated with the IL-18 to some domain of cognition in healthy subjects. However, [@B103] suggests a role of a higher plasmatic level of this cytokine in determining the Visuo-spatial/Constructional deficit that characterizes naïve schizophrenic patients and has resulted in its circulatory level being significantly and positively associated with cognitive impairment in AD patients ([@B9]).

The higher plasma levels of the IL-6, the IL-1β, and the IL-18 contribute to explain the more elevated NF-κB activation observed in freshly isolated PBMCs at the baseline vs. the EG after the MT. Our data prompted the fact that the MT inhibition of pro-inflammatory cytokines release from the PBMCs could be influenced by the restoration of the WIP-1 expression.

Our observations on human are consistent with the previous finding on rodents, in which the gene expression of WIP-1 resulted lower during aging ([@B97]). The PBMCs from older adults at the baseline, in which the WIP-1 expression was lower, were characterized by the higher p65^Ser536^ nuclear translocation when compared to the PBMCs from older adults treated with the MT in which the WIP-1 expression and activity was enhanced.

The analyses of cultured *ex vivo* PBMCs have shown that the WIP-1 could suppress the release of targets of the transcription factor NF-κB (i.e., cytokines medium release), with or without the LPS/INFγ stimulation. Our data also suggests that cultured PBMCs from older adults after the MT participation, were less sensitive toward the LPS/INFγ stimulation.

We are in accordance with the previous study which suggested an inhibiting role of the WIP-1 to the NF-κB signaling pathway. As showed by [@B17], the over-expression of the WIP-1 or silencing it reduced or increased the NF-κB activation downstream treatment with the IL-1β. Once again, it was purposed that the enhancement of the NF-κB activity by the WIP-1 knockdown was strictly due to the levels of phosphorylation of the p65 on the Ser536. We can conclude that the WIP-1 could reduce the release of these cytokines by the inhibition of the NF-κB through direct de-phosphorylation of the p65 sub-unit on the Ser536.

Summarizing, our data confirms the validity of the MT, through mnemonic strategies in counteracting the aging associated decline of verbal, visual memory and of attention. In addition, we first suggested that this method of cognitive training contributes also to improve the other features of the phenotype of older adults by the decreasing level of the circulating C and pro-inflammatory cytokines and inflammation. Nevertheless, we suggest that the effect exerted on cytokines by MT could be due to the restoration of a higher level of the WIP-1 expression and activity.

The main limitation of the study is regards "How" the MT can contribute in restoring the WIP-1 expression and decreasing the pro-inflammatory cytokines level. Considering the associations observed between C, MMSE score, cytokines, and WIP-1 expression, we hypothesized a mechanism in which the lowering of this hormone could represent a potential link between cognitive stimulation and the observed decrease of low-grade inflammation that characterizes older adults.

The MT is a practice based on working memory tasks, which involves the hippocampus and its connections ([@B15]). At the present, we speculate that the MT could contribute to restore the inhibiting role on the HPA axis activity ([@B43]). It is indeed known that the hippocampal type I receptors were strictly expressed in the hippocampus and resulted diminished in aging. These receptors mediated the feedback control of the HPA axis, through the activation of tonic inhibitory projections mediated by GABAergic neurons proceeded to the Para Ventricular Nucleus of the hypothalamus ([@B89]; [@B44]). To follow, the effect of MT on the diminishing C medium level, could determine the modulations on pro-inflammatory cytokines secretion recorded by analysis of *ex vivo* PBMCs. To this end, recent findings suggested that *in vivo* administration of C could enhance the migratory response of human monocytes and decrease the mRNA level of the IkBα protein, leading to higher nuclear levels of the p65 sub-unit of NF-kB ([@B98]). Other studies support the existence of a positive feedback between GCs secretion and the activation of the Toll Like Receptor pro-inflammatory signaling pathway that was mediated by the synergistic action of GCs and pro-inflammatory stimuli ([@B8]; [@B45]). GCs have also been shown to induce the expression of NLRP3 inflammasome, in both cultured and primary macrophages, leading to higher secretion of IL1β, and IL-6 ([@B11]). These results provide a potential explanation for some of the negative effects of higher level of C in older adults ([@B19]).

With regards to the WIP-1 expression, further analysis as to whether its expression in *ex vivo* PBMCs could be modulated by *in vivo* administration of C in young and older adults with or without synergy with pro-inflammatory stimulation will be done in the future. Furthermore, it will be of interest to investigate the age-related promoter status methylation of the PPM1D gene to test the hypothesis that an epigenetic mechanism (e.g., hypermethylation of PPM1D promoter κB site) could contribute to the WIP-1 repression, and could explain the progressive long life reduction of the WIP-1 expression previously observed in several cell types by other studies ([@B97]; [@B104]).

Conclusion
==========

Our work provides insight some new properties of the MT in counteracting aging and a purposely planned WIP-1 deficiency as a part of its pathophysiology, bearing in mind that this phosphatase exerts an important role within the mechanisms that generally act in order to counteract and reduce the negative effects of environmental agents and those which were impaired during adulthood.
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